TMED vs. SURI

Last updated Aug 4, 2026

TMED (T. Rowe Price Health Care ETF) and SURI (Simplify Propel Opportunities ETF) are both Health & Biotech Equities funds. Both are actively managed. Over the past year, TMED returned 41.69% vs 42.96% for SURI. Their 0.41 correlation means their historical movements had little consistent relationship. TMED charges 0.44%/yr vs 2.51%/yr for SURI.

Performance

TMED vs. SURI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in T. Rowe Price Health Care ETF (TMED) and Simplify Propel Opportunities ETF (SURI). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, TMED achieves a 14.31% return, which is significantly lower than SURI's 17.59% return.

TMED

• 1D: 0.28%
• 1M: -2.90%
• 6M: 13.93%
• YTD: 14.31%
• 1Y: 41.69%
• 3Y*: —
• 5Y*: —
• 10Y*: —
• ALL TIME*: 31.40%

SURI

• 1D: 0.08%
• 1M: 0.52%
• 6M: 17.81%
• YTD: 17.59%
• 1Y: 42.96%
• 3Y*: 9.52%
• 5Y*: —
• 10Y*: —
• ALL TIME*: 7.10%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
SURI Simplify Propel Opportunities ETF	$33.33K	$49.11K	$70.76K
TMED T. Rowe Price Health Care ETF	$590.48K	$387.83K	$177.93K

TMED vs. SURI - Yearly Performance Comparison

	2026 (YTD)	2025
TMED T. Rowe Price Health Care ETF	14.31%	19.49%
SURI Simplify Propel Opportunities ETF	17.59%	18.01%

Correlation

The correlation between TMED and SURI is 0.40, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.40
Correlation (All Time) Calculated using the full available price history since Jun 12, 2025	0.41

Return for Risk

TMED vs. SURI — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

TMED

TMED Risk / Return Rank: 87
TMED Sharpe Ratio Rank: 88
TMED Sortino Ratio Rank: 89
TMED Omega Ratio Rank: 85
TMED Calmar Ratio Rank: 87
TMED Martin Ratio Rank: 84

SURI

SURI Risk / Return Rank: 78
SURI Sharpe Ratio Rank: 80
SURI Sortino Ratio Rank: 76
SURI Omega Ratio Rank: 74
SURI Calmar Ratio Rank: 87
SURI Martin Ratio Rank: 74

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

TMED vs. SURI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Health Care ETF (TMED) and Simplify Propel Opportunities ETF (SURI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	TMED	SURI	Difference
Sharpe ratio: Return per unit of total volatility	2.29	1.95	+0.35
Sortino ratio: Return per unit of downside risk	3.32	2.61	+0.70
Omega ratio: Gain probability vs. loss probability	1.39	1.33	+0.07
Calmar ratio: Return relative to maximum drawdown	3.77	3.67	+0.10
Martin ratio: Return relative to average drawdown	12.83	9.75	+3.08

TMED vs. SURI - Sharpe Ratio Comparison

The current TMED Sharpe Ratio is 2.29, which is comparable to the SURI Sharpe Ratio of 1.95. The chart below compares the historical Sharpe Ratios of TMED and SURI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

TMED vs. SURI - Drawdown Comparison

The maximum TMED drawdown since its inception was -11.11%, smaller than the maximum SURI drawdown of -47.76%. Use the drawdown chart below to compare losses from any high point for TMED and SURI.

Drawdown Indicators

	TMED	SURI	Difference
Max Drawdown Largest peak-to-trough decline	-11.11%	-47.76%	+36.65%
Max Drawdown (1Y) Largest decline over 1 year	-11.11%	-11.78%	+0.67%
Max Drawdown (3Y) Largest decline over 3 years	—	-47.76%	—
Current Drawdown Current decline from peak	-3.98%	-8.53%	+4.55%
Average Drawdown Average peak-to-trough decline	-2.42%	-17.07%	+14.65%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.26%	4.42%	-1.16%

Volatility

TMED vs. SURI - Volatility Comparison

T. Rowe Price Health Care ETF (TMED) has a higher volatility of 4.81% compared to Simplify Propel Opportunities ETF (SURI) at 4.13%. This indicates that TMED's price experiences larger fluctuations and is considered to be riskier than SURI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	TMED	SURI	Difference
Volatility (1M) Calculated over the trailing 1-month period	4.81%	4.13%	+0.68%
Volatility (6M) Calculated over the trailing 6-month period	14.06%	14.41%	-0.35%
Volatility (1Y) Calculated over the trailing 1-year period	18.29%	22.20%	-3.91%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	18.11%	27.88%	-9.77%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	18.11%	27.88%	-9.77%

TMED vs. SURI - Expense Ratio Comparison

TMED has a 0.44% expense ratio, which is lower than SURI's 2.51% expense ratio.

Dividends

TMED vs. SURI - Dividend Comparison

TMED's dividend yield for the trailing twelve months is around 0.48%, less than SURI's 15.07% yield.

Position	TTM	2025	2024	2023
SURI Simplify Propel Opportunities ETF	15.07%	16.31%	21.41%	14.71%
TMED T. Rowe Price Health Care ETF	0.48%	0.54%	0.00%	0.00%

Frequently Asked Questions

Can I hold both TMED and SURI in my portfolio?

TMED and SURI have a correlation of 0.40, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, TMED or SURI?

TMED has higher volatility (4.81%) compared to SURI (4.13%). In terms of maximum drawdown, TMED dropped -11.11% vs SURI's -47.76%.

Which ETF is better, TMED or SURI?

On 1-year performance, SURI leads with 42.96% vs 41.69% for TMED. On fees, TMED is cheaper at 0.44% per year. On volatility, SURI has been the lower-risk option at 4.13%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, TMED or SURI?

Over the 1-year period, SURI has performed better with a 42.96% return vs 41.69%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, TMED or SURI?

TMED is cheaper with a 0.44% expense ratio, compared with 2.51% for SURI.

Which ETF pays a higher dividend yield, TMED or SURI?

SURI has the higher dividend yield at 15.07%, compared with 0.48% for TMED.

What is the main difference between TMED and SURI?

They also come from different issuers: T. Rowe Price and Simplify. Their fees differ too: 0.44% for TMED and 2.51% for SURI.

Which has better risk-adjusted returns?

TMED currently has the higher Sharpe Ratio (2.29 vs 1.95), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.